Tcg Crossover Management, LLC Tyra Biosciences, Inc. Transaction History
Tcg Crossover Management, LLC
- $950 Million
- Q1 2024
A detailed history of Tcg Crossover Management, LLC transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Tcg Crossover Management, LLC holds 1,989,103 shares of TYRA stock, worth $31.8 Million. This represents 3.43% of its overall portfolio holdings.
Number of Shares
1,989,103
Previous 1,989,103
-0.0%
Holding current value
$31.8 Million
Previous $27.5 Million
18.41%
% of portfolio
3.43%
Previous 3.81%
Shares
4 transactions
Others Institutions Holding TYRA
# of Institutions
77Shares Held
32.4MCall Options Held
600Put Options Held
3.7K-
Boxer Capital, LLC San Diego, CA6.45MShares$103 Million5.5% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$74.5 Million2.29% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.41MShares$70.5 Million79.77% of portfolio
-
Nextech Invest Ag4.06MShares$64.9 Million12.44% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.39MShares$22.3 Million3.64% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $671M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...